MRNA · 8-K · 20260731PR000147
Liquidity and Cash Position
Moderna, Inc. · 2026-07-31 · Importance 61 · Surprise 32 · No source text
Cash, cash equivalents and investments totaled $6.9 billion at June 30, 2026, down from $7.5 billion at March 31, 2026. Six-month net cash used in operating activities was $1.156 billion, compared with $1.956 billion in the prior-year period. Cash and cash equivalents were $1.723 billion, while current and non-current investments totaled $5.187 billion at June 30, 2026. Moderna projects year-end 2026 cash and investments of $4.7 billion to $5.2 billion and had $0.9 billion remaining under its credit facility.
Key facts
- Year-end cash and investments for 2026 are now projected to be $4.7 to $5.2 billion, an improvement of approximately $0.2 billion. source
- The projected year-end cash and investments range excludes any further drawdowns from the Company's remaining $0.9 billion available under its credit facility. source
- Cash, cash equivalents and investments decreased from $7.5 billion as of March 31, 2026 to $6.9 billion as of June 30, 2026. source
- GAAP net loss for the second quarter of 2026 was $(0.8) billion (net loss $(782) million). source
- Accrued liabilities increased to $1,909 million as of June 30, 2026 from $1,386 million at December 31, 2025. source
- Cash, cash equivalents and investments as of June 30, 2026 were $6.9 billion. source
- Cash, cash equivalents and restricted cash at end of period June 30, 2026 was $1,724 million. source
- Investments (current) as of June 30, 2026 were $3,415 million and non-current investments were $1,772 million. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | probable | — | Year-end cash and investments for 2026 are now projected to be $4.7 to $5.2 billion, an improvement of approximately $0.2 billion. |
| cash | negative | realized | — | Cash, cash equivalents and investments decreased from $7.5 billion as of March 31, 2026 to $6.9 billion as of June 30, 2026. |
| net_income | negative | realized | — | GAAP net loss for the second quarter of 2026 was $(0.8) billion (net loss $(782) million). |
| liability | negative | realized | — | Accrued liabilities increased to $1,909 million as of June 30, 2026 from $1,386 million at December 31, 2025. |
| cash | positive | realized | — | Cash, cash equivalents and investments as of June 30, 2026 were $6.9 billion. |
| liability | negative | realized | — | Long-term debt as of June 30, 2026 was $591 million. |
| assets | positive | realized | — | Total assets as of June 30, 2026 were $10,961 million and total stockholders’ equity was $6,761 million. |
| cash | negative | realized | — | Net cash used in operating activities for the six months ended June 30, 2026 was $(1,156) million. |